Diltiazem hydrochloride sustained-release tablets IP {60mg} . . . . .

Jul 18, 2023

Diltiazem hydrochloride sustained-release tablets IP  {60mg}
DILTITAB 60  
DILTITAB is a medication that belongs to the class of calcium channel blockers. DILTITAB is commonly used to treat various heart conditions, including high blood pressure (hypertension), angina (chest pain), and certain types of irregular heart rhythms (arrhythmias). The sustained-release tablets are formulated to release the medication slowly and continuously over an extended period, allowing for a once-daily dosing regimen.
DILTITAB  works by inhibiting the influx of calcium ions into smooth muscle cells of the heart and blood vessels. By doing so, DILTITAB relaxes and widens the blood vessels, reducing blood pressure and improving blood flow to the heart.
DILTITAB  sustained-release tablets are primarily prescribed for the management of hypertension (high blood pressure). DILTITAB are also used to treat chronic stable angina and to control certain types of arrhythmias, such as atrial fibrillation or atrial flutter.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/diltitab-60-133292
 

SHARE WITH